Top analysts changed outlook on top names, including downgrades, upgrades, and initiations. Check out analyst ratings page for full view.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Guggenheim analyst Brad Canino downgraded Nuvalent, Inc (NASDAQ:NUVL) from Buy to Neutral and lowered the price target from $151 to $124.
Nuvalent shares closed at $123.25 on Tuesday.
See how other analysts view this stock.
Wall Street analysts changed ratings on top stocks. Check out the complete list on Benzinga's analyst ratings page. AMAT was…
Top Wall Street analysts change outlook on top names. See analyst ratings page for changes, including…
Top Wall Street analysts changed outlook on top names; see all changes on analyst ratings page. Analysts have mixed views on ZS…
Wall Street analysts changed outlook on top names. For complete changes, see analyst ratings page. AFRM upgraded, LYB raised…
Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.
Top Wall Street analysts changed outlook on top names. See all analyst rating changes, including upgrades/downgrades, on…
